Prophylactic steroids for pediatric open heart surgery

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 5, 2015, Pages

  Elbarbary, Mahmoud ^a   Madani, Wedad H ^b   Robertson Malt, Suzanne ^c  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PRIORITY JOURNAL; RETRACTED ARTICLE; REVIEW; ADOLESCENT; ADVERSE EFFECTS; CHILD; FEMALE; HEART SURGERY; HUMAN; INFANT; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MALE; META ANALYSIS; NEWBORN; POSTOPERATIVE COMPLICATIONS; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CORTICOSTEROID;

ADOLESCENT; ADRENAL CORTEX HORMONES; CARDIAC SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; MALE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84979853637     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005550.pub3     Document Type: Review

References (55)

1. Bronicki R, Backer C, Baden H, Mavroudis C, Crawford S, Green T. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Annals of Thoracic Surgery 2000;69:1490-5. 2833056
2. Checchia PA, Backer CL, Bronicki RA, Baden HP, Crawford SE, GreenTP, et al. Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Critical Care Medicine 2003;31(6):1742-5. 2833057
3. Keski-Nisula J, Pesonen E, Olkkola KT, Peltola K, Neuvonen PJ, Tuominen N, et al. Methylprednisolone in neonatal cardiac surgery: reduced inflammation without improved clinical outcome. Annals of Thoracic Surgery 2013;95(6):2126-32. 2833059
4. Lerzo F, Peri G, Doni A, Bocca P, Morandi F, Pistorio A, et al. Dexamethasone prophylaxis in pediatric open heart surgery is associated with increased blood long pentraxin PTX3: potential clinical implications. Clinical and Developmental Immunology 2011;2011:6. [DOI: 10.1155/2011/730828]2833061
5. Lindberg L, Forsell C, Jogi P, Olsson K. Effects of dexamethasone on clinical course, C-reactive protein, S100B protein and von Willebrand factor antigen after pediatric cardiac surgery. British Journal of Anaesthesia 2003;90(3):728-32. 2833063
6. Liu J, Ji B, Long C, Li C, Feng Z. Comparative effectiveness of methylprednisolone and zero-balance ultrafiltration on inflammatory response after pediatric cardiopulmonary bypass. Artificial organs 2007;31(7):571-5. 2833065
7. Schroeder V, Pearl JM, Schwartz SM, Shanley TP, Manning PB, Nelson DP. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces post bypass inflammatory mediator expression. Circulation 2003;107:2823-8. 2833067
8. Varan B, Tokel K, Mercan S, Donmez A, Aslamaci S. Systemic inflammatory response related to cardiopulmonary bypass and its modification by methyl prednisolone: High dose versus low dose. Pediatric Cardiology 2002;23:437-41. 2833069
9. Ando M, Park IS, Wada N, Takahashi Y. Steroid supplementation: A legitimate pharmacotherapy after neonatal open heart surgery. The Society of Thoracic Surgeons 2005;80(5):1672-8. 2833071
10. Bocsi J, Hänzka MC, Osmancik P, Hambsch J, Dähnert I, Sack U, et al. Modulation of the cellular and humoral immune response to pediatric open heart surgery by Methylprednisolone. Cytometry. Part B, Clinical Cytometry 2011;80(4):212-20. 2833073
11. Brunow De Carvalho W, Fonseca MCM. Steroids use in pediatric cardiac surgery: More questions. Pediatric Critical Care Medicine 2007;8(5):503-4. 2833075
12. Caputo M, Mokhtari A, Rogers CA, Panayiotou N, Chen Q, Ghorbel MT, et al. The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatoryresponse in cyanotic pediatric patients undergoing open cardiac surgery: a randomized controlled trial. The Journal of Thoracic and Cardiovascular Surgery 2009;138(1):206-14. 2833077
13. Checchia PA, Bronicki RA, Costello JM, Nelson DP. Steroid use before pediatric cardiac operations using cardiopulmonary bypass: An international survey of 36 centers. Pediatric Critical Care 2005;6:441-4. 2833079
14. Chew M, Brandslund I, Brix-Christensen V, Ravn H, Hjortdal V, Pedersen J et.al. Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: a descriptive study. Anesthesiology 2001;94:745-53. 2833081
15. Clarizia NA, Manlhiot C, Schwartz SM, Sivarajan VB, Maratta R, Holtby HM, et al. Improved outcomes associated with intraoperative steroid use in high-risk pediatric cardiac surgery. Annals of Thoracic Surgery 2011;91(4):1222-7. 2833083
16. Duval E, Kavelaars A, Veenhuizen L, van Vught AJ, van de Wal HJ, Heijnen CJ. Pro- and anti-inflammatory cytokine patterns during and after cardiac surgery in young children. European Journal of Pediatrics 1999;158:387-93. 2833085
17. Eguchi S, Aoki E, Hoshino K, Terashima M, Matsuzawa H. Massive administration of corticosteroids during open heart surgery - experimental and clinical studies. Japanese Journal of Thoracic Surgery 1969;22:262-9. 2833087
18. Gessler P, Hohl V, Carrel T, Pfenninger J, Schmid ER, Baenziger O, et al. Administration of steroids in pediatric cardiac surgery: Impact on clinical outcome and systemic inflammatory response. Pediatric Cardiology 2005;26:595-600. 2833089
19. Heying R, Wehage E, Schumacher K, Tassani P, Haas F, Lange R, et al. Dexamethasone pretreatment provides antiinflammatory and myocardial protection in neonatal arterial switch operation. Annals of Thoracic Surgery 2012;93(3):869-76. 2833091
20. Malagon I, Onkenhout W, Klok M, Linhorst L, van de Poel P, Bovill J, et al. Dexamethasone reduces gut permeability in pediatric cardiac surgery. Journal of Thoracic & Cardiovascular Surgery 2005;130(2):265-71. 2833093
21. Malagon I, Hogenbirk K, van P, Hazekamp M, Bovill J. Effect of dexamethasone on postoperative cardiac troponin T production in pediatric cardiac surgery. Intensive Care Medicine 2005;31:1420-6. 2833095
22. Mott A, Fraser C, Kusnoor A, Giesecke N, Ruel G, Drescher K, et al. The effect of short-term prophylactic methylprednisolone on the incidence and severity of postpericardiotomy syndrome in children undergoing cardiac surgery with cardiopulmonary bypass. Journal of the American College of Cardiology 2001;37(6):1700-6. 2833097
23. Pasquali SK, Hall M, Li JS, Peterson ED, Jaggers J, Lodge AJ, et al. Corticosteroids and outcome in children undergoing congenital heart surgery: analysis of the pediatric health information systems database. Circulation 2010;122(21):2123-30. 2833099
24. Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, et al. Perioperative methylprednisolone and outcome in neonates undergoing heart surgery. Pediatrics 2012;129(2):385-91. 2833101
25. Santos AR, Heidemann SM, Walters HL, Delius RE. Effect of inhaled corticosteroid on pulmonary injury and inflammatory mediator production after cardiopulmonary bypass in children. Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2007;8(5):465-9. 2833103
26. Sasser WC, Robert SM, Carlo WF, Borasino S, Dabal RJ, Kirklin JK, et al. Postoperative serum cortisol concentration and adrenal insufficiency in neonates undergoing open-heartsurgery. World Journal for Pediatric and Congenital Heart Surgery 2012;3(2):214-20. 2833105
27. Shore S, Nelson D, Pearl J, Manning P, Wong H, Shanley TP, et.al . Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. American Journal of Cardiology 2001;88(5):591-4. 2833107
28. Toledo-Pereyra L, Lin C, Kundler H, Replogle R. Steroids in heart surgery: a clinical double-blind and randomized study. American Surgeon 1980;46:155-60. 2833109
29. Verweij EJ, Hogenbirk K, Roest AA, van Brempt R, Hazekamp MG, de Jonge E. Serum cortisol concentration with exploratory cut-off values do not predict the effects of hydrocortisone administration in children with low cardiac output after cardiac surgery. Interactive Cardiovascular and Thoracic Surgery 2012;15(4):685-9. 2833111
30. Wilson NJ, Weber SA, Peterson MWH, Sandor GGS, Tipple M, LeBlanc J. Double-blinded placebo controlled trial of corticosteroids in children with postpericardiotomy syndrome. Pediatric Cardiology 1994;15:62-5. 2833113
31. Burdette SD, Parilo M, Kaplan L. Systemic Inflammatory Response Syndrome. http://www.emedicine.com/med/topic2227.htm (accessed 14 July 2004).
32. Casey LC. Roles of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Annals of Thoracic Surgery 1993;56(5 Suppl):S92-6.
33. Clapp SK. Postoperative inflammatory syndromes. In: Garson A, Bricker JT, Fisher DJ, Neish SR editor(s). The Science and Practice of Pediatric Cardiology. 2nd Edition. Williams and Wilkins, 1998:1817-21.
34. Drusin LM, Engle MA, Hagstrom WC, Schwartz MS. The postpericardiotomy syndrome: a six-year epidemiologic study. New England Journal of Medicine 1965;272:597-602.
35. el-Barbary M, Khabar KS. Soluble tumor necrosis factor receptor p55 predicts cytokinemia and systemic inflammatory response after cardiopulmonary bypass. Critical Care Medicine 2002;30(8):1712-6. [MEDLINE: PMID: 12163781]
36. Friedrich B, Schmidt R, Reiss I, Gunther A, Seeger W, Muller M, at al. Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children. Critical Care Medicine 2003;31(1):284-90.
37. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
38. Higgins JPT. The Cochrane Collaboration. Version 5.1.0. Cochrane Handbook for Systematic Reviews of Interventions, March 2011.
39. Jacobs ML, O'Brien SM, Jacobs JP, Mavroudis C, Lacour-Gayet F, Pasquali SK, et al. An empirically based tool for analyzing morbidity associated with operations for congenital heart disease. Thoracic and Cardiovascular Surgeon 2013;145(4):1046-57. [DOI: 10.1016/j.jtcvs.2012.06.029]
40. Johnson MR. Low systemic vascular resistance after cardiopulmonary bypass: Are we any closer to understanding the enigma?. Critical Care Medicine 1999;27(6):1048-50.
41. Khabar KS, elBarbary MA, Khouqeer F, Devol E, al-Gain S, al-Halees Z. Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clinical Immunology and Immunopathology 1997;103:97. [MEDLINE: PMID: 9325075]
42. Kimmel SC, van de Stouwe MJ, Levin RI, Weissmann G, Cronstein BN. A final common pathway for antiinflammatory agents: inhibition of leukocyte-endothelial interactions. Transactions of the Association of American Physicians 1991;104:113-24.
43. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of InterventionsVersion 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
44. Lequier LL, Nikaidoh H, Leonard SR, Bokovoy JL, White ML, Scannon PJ, et al. Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest 2000;117(6):1706-12.
45. Maharaj C, Laffey JG. New strategies to control the inflammatory response in cardiac surgery. Current Opinion in Anaesthesiology 2004;17(1):35-48.
46. Mayumi H, Zhang QW, Nakashima A, Matsuda M, Kohno H, Kawachi Y, et al. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Annals of Thoracic Surgery 1997;63:129-37.
47. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
48. Morton JR, Hiebert CA, Lutes, White RL. Effect of methylprednisolone on myocardial preservation during coronary artery surgery. American Journal of Surgery 1976;131:419-22.
49. Niazi Z, Flodin P, Joyce L, Smith J, Mauer H, Lillehei RC. Effects of glucocorticosteroids in patients undergoing coronary artery bypass surgery. Chest 1979;76:262-8.
50. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
51. Scrascia G, Rotunno C, Guida P, Amorese L, Polieri D, Codazzi D, et al. Perioperative steroids administration in pediatric cardiac surgery: a meta-analysis of randomized controlled trials. Pediatric Critical Care Medicine 2014;15(5):435-42. [DOI: 10.1097/PCC.0000000000000128]
52. Seghaye MC, Engelhardt W, Grabitz RG, Faymonville ME, Hornchen H, Messmer BJ, et al. Multiple system organ failure after open heart surgery in infants and children. Thoracic & Cardiovascular Surgeon 1993;41(1):49-53.
53. Tarnok A, Schneider P. Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to transient systemic immune suppression. Shock 2001;16(Suppl 1):24-32.
54. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. New England Journal of Medicine 2001;345(19):1359-67.
55. Wakabayashi G, Ueda M, Shimazu M, et al. Pro and anti-inflammatory cytokines production from human monocytes -The effect of methylprednisolone. Dig Organ Immunol 1993;28:13-7.